From 'Made in China' to 'Created in China': Science Scaling C-Beauty

NEW YORK, NY – October 05, 2026

For decades, the global business community viewed the Chinese cosmetics industry through a narrow lens: a powerhouse of rapid manufacturing and aggressive digital marketing, but rarely the birthplace of fundamental scientific breakthroughs. That outdated narrative was definitively dismantled last week in Perth, Australia.

At the 36th Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC)—an event widely regarded as the "Nobel Prize of the cosmetics industry"—Chinese beauty conglomerate CHANDO Group presented a staggering 20 research papers. This record-breaking acceptance rate placed the company among the top five corporate contributors worldwide, standing shoulder-to-shoulder with legacy Western conglomerates.

As someone who tracks the business implications of complex organizational change, I see this as far more than a cosmetics story. It is a clear indicator of a broader industrial pivot. Leading Chinese enterprises are actively shifting from "Made in China" to "Created in China," transitioning away from marketing-led growth toward deep investments in AI-driven research, sustainable biotechnology, and localized genomics. The era of C-beauty as a "cheap dupe" is officially over; rigorous innovation is the new baseline.

Decoding the Epigenetics of Asian Skin

One of the most significant pitfalls for global beauty brands has been the historical reliance on Western study populations for skin-aging research. This has left a massive data gap regarding the characteristics, timing, and contributing factors of skin aging among Asian consumers.

To bridge this gap, CHANDO Group partnered with the Shanghai Institute of Nutrition and Health of the Chinese Academy of Sciences. Together, they conducted a rigorous two-year longitudinal cohort study, systematically comparing facial-aging phenotype data from more than 5,000 Chinese participants over a five-year period from 2018 to 2023.

The findings are a wake-up call for product developers. The study revealed that facial wrinkle aging among Chinese women in recent years has tended to begin earlier and progress more rapidly. Crucially, researchers quantified the differing effects of modern, fatigue-related lifestyle factors—such as shorter sleep duration and the earlier initiation of smoking and alcohol consumption—on specific types of wrinkles.

This data supports a strategic shift from generalized anti-aging products toward what the company terms "precision anti-fatigue aging." Furthermore, their research into longevity science identified the epigenetic regulator microRNA-1290 as a key "switch" involved in photoaging-related telomere depletion in Chinese women. By treating this with a proprietary Himalayan-derived filtrate, researchers could significantly reverse the effect. For business leaders, the lesson is clear: hyper-localized, data-backed interventions are rapidly outpacing one-size-fits-all solutions.

AI and the End of Guesswork in R&D

Identifying a highly specific consumer need is only half the battle; developing the right active ingredient to address it has traditionally been a slow, inefficient process of trial and error. Here, we see another hallmark of the future of work: the integration of artificial intelligence into fundamental research.

Building on its insights into fatigue-induced aging, CHANDO Group collaborated with the ACRDC R&D Center at the Yangtze Delta Region Institute of Tsinghua University to establish an AI-driven peptide discovery platform. Utilizing AI-powered computational biology, the platform screened and optimized candidates from more than 2.8 million yeast proteins.

This massive computational effort led to the discovery of the HiMurchaSin Super Anti-Aging Peptide, an ingredient that targets PGC-1α, a key regulator of mitochondrial energy metabolism. By promoting mitochondrial biogenesis, the ingredient directly supports precision anti-fatigue aging.

From a business perspective, the application of AI in this context is transformative. It dramatically accelerates the R&D timeline, reduces the capital historically wasted on dead-end molecular screening, and allows companies to bring highly efficacious, patented ingredients to market with unprecedented speed. Beyond speed, this proprietary AI platform provides a critical strategic advantage: independence. By discovering and patenting its own core ingredients, the organization reduces its reliance on third-party Western ingredient suppliers, protecting its margins and creating a defensible intellectual property moat.

Sustainable Biotech: Mining the Himalayas in a Lab

The push for innovation often collides with the realities of environmental, social, and governance (ESG) mandates. The Himalayas are a rich source of extremophile botanicals. However, relying on wild-harvested rare plants is an ecological liability and a severe supply chain vulnerability.

A prime example is Saussurea laniceps, commonly known as the cotton-headed snow lotus. Native to high-altitude Himalayan regions, it is classified in China as a nationally protected Class II endangered wild plant. Historically over-collected, its natural populations have severely declined over the past century.

Rather than abandoning the ingredient or risking ecological harm, the corporate R&D team utilized plant callus tissue culture technology. Operating with required regulatory approvals and filing the resulting extract as a new cosmetic ingredient with China's National Medical Products Administration, the team successfully cultivated the material in a laboratory setting.

This method requires minimal initial plant material and enables standardized, scalable production of highly active skin-brightening compounds without depleting wild populations. This approach highlights a critical capability for resilient organizations: leveraging biotechnology to decouple product innovation from ecological extraction. As sustainability transitions from a marketing buzzword to a strict regulatory requirement, lab-grown botanical alternatives offer a blueprint for future-proofing supply chains.

This scientific rigor is not limited to facial skincare. The research presented in Perth demonstrated a sweeping expansion into broader personal wellness categories. Moving beyond conventional broad-spectrum antimicrobial approaches, researchers unveiled targeted microbiome modulation for scalp care to address hair loss. Similarly, they introduced probiotic extracellular vesicle research for women's intimate care, and selective cleansing technologies utilizing bicontinuous-phase systems. This diversification indicates a strategic land-grab across the entire personal care spectrum, underpinned by rigorous biological research.

The Broader Business Implication: A Global Mandate

The aggressive R&D investments by leading domestic players—which reported revenues in the billions and are actively expanding their e-commerce dominance—reflect a rapidly maturing industry. Chinese beauty companies are no longer content to simply capture domestic market share through influencer marketing and social selling. They are building comprehensive innovation ecosystems that span fundamental research, ingredient development, and clinical validation.

This scientific elevation is gaining undeniable international recognition. At the 2025 IFSCC Congress in Cannes, Chinese companies ranked second worldwide in oral presentations. The fact that China has secured the right to host the 2032 IFSCC Congress further cements its growing profile in the global scientific community.

For legacy multinational conglomerates, the competitive landscape has fundamentally changed. The moat built on decades of proprietary European or American research is being aggressively challenged by agile, tech-forward organizations that are combining AI, sustainable biotech, and massive localized datasets. Leaders across all sectors should take note: the transition from "Made in China" to "Created in China" is not a future possibility, but a present reality that is reshaping the global standards of innovation.